Skip to main content
Qiuying Chen on Muck Rack

Qiuying Chen

As seen in: Wiley Online Library, Frontiers, MDPI, ACS Publications, Medscape, BioRxiv, Cell Press, EClinicalMedicine, eLife, Texas Medical Center and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Qiuying

Contact Qiuying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Transcription Factor ATF4 Deletion Reprograms Glucose Metabolism in Clear Cell Renal Cell Carcinoma.

|
By Qiuying Chen, Steven Gross, John Wagner
| UroToday Verified
Background/Objectives: Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer. Human ccRCCs have increased glycolytic metabolism and decreased mitochondrial oxidative metabolism relative to normal kidneys.
Open in Who Shared Issue with article?

The denitrosylase SCoR2 controls cardioprotective metabolic reprogramming

|
By Zachary W. Grimmett, Rongli Zhang, Hua-Lin Zhou, Qiuying Chen
| eLife
eLife Assessment This study provides new and interesting findings that SCoR2 acts as a denitrosylase to control cardioprotective metabolic reprogramming and prevent injury following ischemia/reperfusion. The compelling evidence is supported by a novel multi-omics approach, but questions remain regarding the stability and human relevance of BDH1 as well as the sufficiency of SCoR2.
Open in Who Shared Issue with article?

The denitrosylase SCoR2 controls cardioprotective metabolic reprogramming

|
By Zachary W. Grimmett, Rongli Zhang, Hua-Lin Zhou, Qiuying Chen
| BioRxiv
Abstract Acute myocardial infarction (MI) is a leading cause of morbidity and mortality, and therapeutic options remain limited. Endogenously generated nitric oxide (NO) is highly cardioprotective, but protection is not replicated by nitroso-vasodilators (e.g., nitrates, nitroprusside) used in clinical practice, highlighting specificity in NO-based signaling and untapped therapeutic potential.
Open in Who Shared Issue with article?
See all 21 articles